Crohn's disease phenotype, prognosis, and long-term complications : what to expect ?

被引:0
|
作者
Cosnes, Jacques [1 ,2 ]
机构
[1] Hop St Antoine, Serv Gastroenterol & Nutr, F-75571 Paris, France
[2] Univ Paris 06, Paris, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
According to Montreal classification, different phenotypes of Crohn's disease are defined taking into account age at diagnosis, localization of digestive lesions at first surgery, and cumulative anatomical behaviour. This classification is supported by the increased severity of the disease when diagnosed in childhood, the relative stability of disease localization over time, and the clinical importance of intestinal complications as stricture and abscess or fistula formation. However, type and delay of complications are dependent on disease localization (they develop early in small bowel disease and late in colitis), every patient will develop complications one day, and perianal disease may be an important problem observed in up to half the patients. The percentage of patients with active disease every year remains stable, about 40%, after the 3 first years, and only a few patients have long periods of remission. Intestinal resections are required in the majority of patients during life, and many are operated on several times. Prognosis is hampered by iterative surgery, cancer and side-effects of treatment. Standardized mortality ratio is 1.50. Although occurrence of complications, need for surgery and mortality did not change significantly through the years 1950-2000, there are some signals suggesting that new therapetic strategies (immunosuppressants earlier in high risk patients) and biologics will modify natural history and improve the long term prognosis. (Acta gastroenterol. belg., 2008, 71, 303-307).
引用
收藏
页码:303 / 307
页数:5
相关论文
共 50 条
  • [31] Antitubercular Therapy Improves Clinical Symptoms of Crohn's Disease Initially but Long-term Complications Are High
    Bhargavi, A.
    Bhagya, G.
    Banerjee, R.
    Reddy, D. N.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : E120 - E120
  • [32] Long-term durability of response to adalimumab in Crohn's disease
    Chaparro, M.
    Panes, J.
    Garcia, V.
    Merino, O.
    Nos, P.
    Domenech, E.
    Penalva, M.
    Garcia-Planella, E.
    Esteve, M.
    Hinojosa, J.
    Andreu, M.
    Munoz, F.
    Gutierrez, A.
    Mendoza, J. L.
    Barrio, J.
    Barreiro-de Acosta, M.
    Vera, I.
    Vilar, P.
    Cabriada, J. L.
    Montoro, M. A.
    Aldeguer, X.
    Saro, C.
    Gisbert, J. P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (04) : 685 - 690
  • [33] Understanding Infliximab in Crohn's Disease: The Long-Term Outcomes
    Turner, Dan
    Lev-Tzion, Raffi
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (03) : 604 - 607
  • [34] Strictureplasty for Crohn's disease: Techniques and long-term results
    Hurst, RD
    Michelassi, F
    [J]. WORLD JOURNAL OF SURGERY, 1998, 22 (04) : 359 - 363
  • [35] LONG-TERM FATE OF THE EXCLUDED RECTUM IN CROHN'S DISEASE
    Yzet, Clara
    Kassim, Gasan
    Nair, Nilendra
    Colombel, Jean Frederic
    Sachar, David B.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S859 - S859
  • [36] INFLIXIMAB IN CROHN'S DISEASE: LONG-TERM DURABILITY EXPERIENCE
    Dibb, M. J.
    Kemp, K.
    Johnson, C.
    Watson, A.
    Makin, A.
    Campbell, S.
    [J]. GUT, 2009, 58 : A94 - A95
  • [37] Long-term outcomes of thalidomide in pediatric Crohn's disease
    Wang, Lin
    Xue, Aijuan
    Zheng, Cuifang
    Zhou, Ying
    Wang, Yuhuan
    Huang, Ying
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (07) : 1124 - 1129
  • [38] Understanding Infliximab in Crohn’s Disease: The Long-Term Outcomes
    Dan Turner
    Raffi Lev-Tzion
    [J]. Digestive Diseases and Sciences, 2013, 58 : 604 - 607
  • [39] Long-term Therapy with Sargramostim in a Patient with Crohn's Disease
    Wong, Alan C.
    Lee, Scott D.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (06) : 1447 - 1448
  • [40] Infliximab in Crohn's disease: early and long-term treatment
    Armuzzi, A.
    De Pascalis, B.
    Fedeli, P.
    De Vincentis, F.
    Gasbarrini, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S271 - S279